Merck (Germany) Top Insiders

MRK Stock  EUR 127.40  1.20  0.95%   
Merck employs about 62.3 K people. The company is managed by 42 executives with a total tenure of roughly 274 years, averaging almost 6.0 years of service per executive, having 1484.43 employees per reported executive. Examination of Merck's management performance can provide insight into the company performance.
Kenneth Frazier  Chairman
Chairman of the Board, President, Chief Executive Officer
Jennifer Zachary  President
Executive Vice President, General Counsel, Corporate Secretary
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merck Company. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.

Merck Management Team Effectiveness

The company has return on total asset (ROA) of 0.0528 % which means that it generated a profit of $0.0528 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1032 %, meaning that it generated $0.1032 on every $100 dollars invested by stockholders. Merck's management efficiency ratios could be used to measure how well Merck manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Merck's Intangible Assets are most likely to increase significantly in the upcoming years.

Merck Quarterly Income Before Tax

1.12 Billion

The current Common Stock Shares Outstanding is estimated to decrease to about 347.8 M. The current Net Income Applicable To Common Shares is estimated to decrease to about 2.3 BMerck Company maintains a total of 129.24 Million outstanding shares. Over half of Merck's outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that shop for positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Merck Company. Please watch out for any change in the institutional holdings of Merck Company as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
 
Shares in Circulation  
First Issued
2016-12-31
Previous Quarter
434.8 M
Current Value
434.8 M
Avarage Shares Outstanding
445.3 M
Quarterly Volatility
339.4 M
 
Covid
 
Interest Hikes
Some institutional investors establish a significant position in stocks such as Merck in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Merck, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Merck Workforce Comparison

Merck Company is considered to be number one stock in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 102,571. Merck totals roughly 62,346 in number of employees claiming about 61% of equities under Health Care industry.
The company has Profit Margin (PM) of 0.14 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.23 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.23.

Merck Company Benchmark Summation

The output start index for this execution was one with a total number of output elements of sixty. The Lowest value over a specified period line plots minimum value of Merck Company price series.

Merck Notable Stakeholders

A Merck stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Merck often face trade-offs trying to please all of them. Merck's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Merck's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Kenneth FrazierChairman of the Board, President, Chief Executive OfficerProfile
Jennifer ZacharyExecutive Vice President, General Counsel, Corporate SecretaryProfile
Julie GerberdingExecutive Vice President and Chief Patient Officer, Strategic Communications, Global Public Policy and Population HealthProfile
Rita KarachunSenior Vice President - Finance, Global ControllerProfile
Robert DavisExecutive Vice President, Global Services, Chief Financial OfficerProfile
Michael NallyExecutive Vice President, Chief Marketing OfficerProfile
Roger PerlmutterExecutive Vice President and Presidentident - Merck Research LaboratoriesProfile
Steven MizellExecutive Vice President, Chief Human Resources Officer, Human ResourcesProfile
Sanat ChattopadhyayExecutive Vice President and President - Merck Manufacturing DivisionProfile
Richard DeLucaExecutive Vice President and Presidentident - Merck Animal HealthProfile
Helene RoederCFO BoardProfile
Thomas GlocerIndependent DirectorProfile
Christine SeidmanIndependent DirectorProfile
Kathy WardenIndependent DirectorProfile
Paul RothmanIndependent DirectorProfile
Mary CoeIndependent DirectorProfile
Peter WendellIndependent DirectorProfile
Leslie BrunLead Independent DirectorProfile
Inge ThulinIndependent DirectorProfile
Pamela CraigIndependent DirectorProfile
Patricia RussoIndependent DirectorProfile
Thomas CechIndependent DirectorProfile
Matthias HeinzelCEO BoardProfile
Gerhard SchmitzHead AccountingProfile
Constantin FestHead RelationsProfile
Khadija HammadaMember OfficerProfile
Jean WirthMember ScienceProfile
Michael FlemingSenior Vice President Chief Ethics and Compliance OfficerProfile
Peter GuenterCEO BoardProfile
Barbara WeilandChief OfficerProfile
Belen MDChair CEOProfile
Marcus KuhnertCFO BoardProfile
Friederike RotschGroup ComplianceProfile
Dirk ToepferChief OfficerProfile
Franklin ClyburnExecutive Vice President Chief Commercial OfficerProfile
Dean LiExecutive Vice President and Presidentident, Merck Research LaboratoriesProfile
Kai BeckmannDeputy BoardProfile
Michael HeckmeierHead MaterialsProfile
Frank GotthardtHead EuropeProfile
Danny MDMember HealthcareProfile
Marc HornHead ControllingProfile
Florian SchraederHead RelationsProfile
String symbol = request.getParameter("s");

About Merck Management Performance

The success or failure of an entity such as Merck Company often depends on how effective the management is. Merck management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Merck management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Merck management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. MERCK Kommanditgesellschaft auf Aktien operates as a subsidiary of E. MERCK KGAA operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 57850 people.

Merck Workforce Analysis

Traditionally, organizations such as Merck use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Merck within its industry.

Merck Manpower Efficiency

Return on Merck Manpower

Revenue Per Employee339.3K
Revenue Per Executive503.7M
Net Income Per Employee44.5K
Net Income Per Executive66.1M
Working Capital Per Employee34.6K
Working Capital Per Executive51.3M

Complementary Tools for Merck Stock analysis

When running Merck's price analysis, check to measure Merck's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck is operating at the current time. Most of Merck's value examination focuses on studying past and present price action to predict the probability of Merck's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merck's price. Additionally, you may evaluate how the addition of Merck to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world